{
    "drug_name_en": "dapagliflozin",
    "side_effects": {
        "Genitourinary": {
            "Common": [
                [
                    "urinary tract infections increased urination",
                    "discomfort with urination",
                    "female genital mycotic infections (including vulvovaginal mycotic infection",
                    "vaginal infection",
                    "vulvovaginalcandidiasis",
                    "vulvovaginitis",
                    "genital infection",
                    "genital candidiasis fungal genital infection",
                    "vulvitis",
                    "genitourinary tract infection",
                    "vulval abscess",
                    "and vaginitis bacterial)",
                    "and male mycotic infections (including balanitis",
                    "fungal genital infection",
                    "balanitis candida",
                    "genital candidiasis",
                    "genital infection male",
                    "penile infection",
                    "balanoposthitis",
                    "balanoposthitis infective",
                    "genital infection",
                    "posthitis)"
                ]
            ],
            "Postmarketing reports": [
                [
                    "urosepsis",
                    "pyelonephritis",
                    "fournier's gangrene"
                ]
            ]
        },
        "Cardiovascular": {
            "Common": [
                [
                    "dyslipidemia"
                ]
            ],
            "Uncommon": [
                [
                    "adverse reactions related to reduced intravascular volume (posturalhypotension",
                    "orthostatic hypotension",
                    "hypotension",
                    "dehydration",
                    "and syncope)"
                ]
            ]
        },
        "Metabolic": {
            "Very common": [
                [
                    "hypoglycemia (up to 43%)"
                ]
            ],
            "Common": [
                [
                    "hyperphosphatemia",
                    "increases in low-density lipoprotein cholesterol (ldl-c)"
                ]
            ],
            "Uncommon": [
                [
                    "decreased weight"
                ]
            ],
            "Postmarketing reports": [
                [
                    "acidosis including diabetic ketoacidosis",
                    "ketoacidosis",
                    "or ketosis"
                ]
            ]
        },
        "Gastrointestinal": {
            "Common": [
                [
                    "nausea",
                    "constipation"
                ]
            ],
            "Uncommon": [
                [
                    "thirst",
                    "dry mouth"
                ]
            ]
        },
        "Hypersensitivity": {
            "Rare": [
                [
                    "serious anaphylactic reactions",
                    "severe cutaneous reactions",
                    "and angioedema"
                ]
            ]
        },
        "Musculoskeletal": {
            "Common": [
                [
                    "back pain",
                    "extremity pain"
                ]
            ],
            "Frequency not reported": [
                [
                    "bone fracture"
                ]
            ]
        },
        "Immunologic": {
            "Common": [
                [
                    "influenza"
                ]
            ]
        },
        "Oncologic": {
            "Uncommon": [
                [
                    "bladder cancer"
                ]
            ]
        },
        "Renal": {
            "Frequency not reported": [
                [
                    "renal failure",
                    "serum creatinine increase"
                ]
            ],
            "Postmarketing reports": [
                [
                    "acute kidney injury",
                    "renal impairment"
                ]
            ]
        },
        "Endocrine": {
            "Frequency not reported": [
                [
                    "small increases in serumparathyroid hormonelevels"
                ]
            ]
        },
        "Nervous system": {
            "Common": [
                [
                    "dizziness",
                    "headache"
                ]
            ]
        },
        "Hepatic": {
            "Very rare": [
                [
                    "hepatitis"
                ]
            ]
        },
        "Respiratory": {
            "Common": [
                [
                    "nasopharyngitis"
                ]
            ]
        },
        "Dermatologic": {
            "Postmarketing reports": [
                [
                    "rash"
                ]
            ]
        }
    }
}